$ACT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allergan Finance LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Allergan Finance LLC. Get notifications about new insider transactions in Allergan Finance LLC for free.
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 26.14 | 7,858 | 205,408 | 0 | |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 26.14 | 4,142 | 108,272 | 0 | |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 26.40 | 2,854 | 75,346 | 0 | |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 26.40 | 2,141 | 56,522 | 0 | |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 27.88 | 3 | 84 | 0 | |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Sell | S | 65.46 | 2,924 | 191,405 | 3,283 | 6.2 K to 3.3 K (-47.11 %) |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Sell | S | 65.46 | 6,616 | 433,083 | 66,043 | 72.7 K to 66 K (-9.11 %) |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 35.11 | 750 | 26,333 | 72,659 | 71.9 K to 72.7 K (+1.04 %) |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 26.14 | 7,858 | 205,408 | 71,909 | 64.1 K to 71.9 K (+12.27 %) |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 26.14 | 4,142 | 108,272 | 64,051 | 59.9 K to 64.1 K (+6.91 %) |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 26.40 | 2,854 | 75,346 | 59,909 | 57.1 K to 59.9 K (+5.00 %) |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 26.40 | 2,141 | 56,522 | 57,055 | 54.9 K to 57.1 K (+3.90 %) |
| Aug 26 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 27.88 | 3 | 84 | 54,914 | 54.9 K to 54.9 K (+0.01 %) |
| Aug 15 2011 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 64.75 | 1,000 | 64,745 | 7,177 | 8.2 K to 7.2 K (-12.23 %) |
| Aug 08 2011 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Sell | S | 62.51 | 3,953 | 247,102 | 35,907 | 39.9 K to 35.9 K (-9.92 %) |
| Aug 01 2011 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Gift | G | 0.00 | 4,000 | 0 | 25,618 | 29.6 K to 25.6 K (-13.51 %) |
| Jul 28 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 64.18 | 1,498 | 96,142 | 0 | |
| Jul 28 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 64.18 | 147 | 9,434 | 0 | |
| Jul 28 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 64.18 | 5,855 | 375,774 | 0 | |
| Jul 28 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Sell | S | 68.41 | 7,202 | 492,689 | 54,911 | 62.1 K to 54.9 K (-11.59 %) |
| Jul 28 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 64.18 | 1,498 | 96,142 | 62,113 | 60.6 K to 62.1 K (+2.47 %) |
| Jul 28 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 64.18 | 147 | 9,434 | 60,615 | 60.5 K to 60.6 K (+0.24 %) |
| Jul 28 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 64.18 | 5,855 | 375,774 | 60,468 | 54.6 K to 60.5 K (+10.72 %) |
| May 31 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Exec VP,General Cou ... | Option Exercise | M | 54.48 | 5,600 | 305,088 | 0 | |
| May 31 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Exec VP,General Cou ... | Option Exercise | M | 54.48 | 1,400 | 76,272 | 0 | |
| May 31 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Exec VP,General Cou ... | Sell | S | 64.10 | 7,000 | 448,700 | 66,572 | 73.6 K to 66.6 K (-9.51 %) |
| May 31 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Exec VP,General Cou ... | Buy | M | 54.48 | 5,600 | 305,088 | 73,572 | 68 K to 73.6 K (+8.24 %) |
| May 31 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Exec VP,General Cou ... | Buy | M | 54.48 | 1,400 | 76,272 | 67,972 | 66.6 K to 68 K (+2.10 %) |
| Jun 01 2011 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 64.45 | 2,635 | 169,826 | 27,722 | 30.4 K to 27.7 K (-8.68 %) |
| May 17 2011 | ACT | Actavis, Inc. | WEISS FRED G | Director | Grant | A | 0.00 | 3,177 | 0 | 22,511 | 19.3 K to 22.5 K (+16.43 %) |
| May 17 2011 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Grant | A | 0.00 | 3,177 | 0 | 8,177 | 5 K to 8.2 K (+63.54 %) |
| May 17 2011 | ACT | Actavis, Inc. | TAYLOR RONALD R | Director | Grant | A | 0.00 | 3,177 | 0 | 23,178 | 20 K to 23.2 K (+15.88 %) |
| May 17 2011 | ACT | Actavis, Inc. | Tabatznik Anthony Selwyn | Director | Grant | A | 0.00 | 3,177 | 0 | 3,177 | 0 to 3.2 K |
| May 17 2011 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Grant | A | 0.00 | 3,177 | 0 | 13,177 | 10 K to 13.2 K (+31.77 %) |
| May 17 2011 | ACT | Actavis, Inc. | HUMMEL ALBERT F | Director | Grant | A | 0.00 | 3,177 | 0 | 137,691 | 134.5 K to 137.7 K (+2.36 %) |
| May 17 2011 | ACT | Actavis, Inc. | KLEMA CATHY | Director | Grant | A | 0.00 | 3,177 | 0 | 24,845 | 21.7 K to 24.8 K (+14.66 %) |
| May 17 2011 | ACT | Actavis, Inc. | FELDMAN MICHEL J | Director | Grant | A | 0.00 | 3,177 | 0 | 13,177 | 10 K to 13.2 K (+31.77 %) |
| May 17 2011 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Grant | A | 0.00 | 3,177 | 0 | 29,618 | 26.4 K to 29.6 K (+12.02 %) |
| May 17 2011 | ACT | Actavis, Inc. | BODINE CHRIS W | Director | Grant | A | 0.00 | 3,177 | 0 | 12,465 | 9.3 K to 12.5 K (+34.21 %) |
| May 09 2011 | ACT | Actavis, Inc. | HUMMEL ALBERT F | Director | Sell | S | 63.36 | 15,000 | 950,400 | 134,514 | 149.5 K to 134.5 K (-10.03 %) |
| May 05 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 26.40 | 5,000 | 132,000 | 2,854 | |
| May 05 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Option Exercise | M | 27.88 | 7,500 | 209,100 | 0 | |
| May 05 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Sell | S | 62.91 | 8,018 | 504,412 | 54,613 | 62.6 K to 54.6 K (-12.80 %) |
| May 05 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 26.40 | 5,000 | 132,000 | 62,631 | 57.6 K to 62.6 K (+8.68 %) |
| May 05 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Buy | M | 27.88 | 7,500 | 209,100 | 57,631 | 50.1 K to 57.6 K (+14.96 %) |
| Mar 18 2011 | ACT | Actavis, Inc. | PAONESSA ALBERT III | EVP & COO of Anda, ... | Sell | S | 54.59 | 2,000 | 109,180 | 42,531 | 44.5 K to 42.5 K (-4.49 %) |
| Mar 15 2011 | ACT | Actavis, Inc. | PAONESSA ALBERT III | EVP & COO of Anda, ... | Payment of Exercise | F | 56.89 | 899 | 51,144 | 44,531 | 45.4 K to 44.5 K (-1.98 %) |
| Mar 15 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Grant | A | 0.00 | 3,594 | 0 | 50,131 | 46.5 K to 50.1 K (+7.72 %) |
| Mar 15 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Exec Vice Pres. & C ... | Payment of Exercise | F | 56.89 | 544 | 30,948 | 46,537 | 47.1 K to 46.5 K (-1.16 %) |
| Mar 15 2011 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Payment of Exercise | F | 56.89 | 616 | 35,044 | 30,357 | 31 K to 30.4 K (-1.99 %) |
| Mar 15 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Exec VP,General Cou ... | Grant | A | 0.00 | 3,594 | 0 | 66,572 | 63 K to 66.6 K (+5.71 %) |
| Mar 15 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Exec VP,General Cou ... | Payment of Exercise | F | 56.89 | 1,375 | 78,224 | 62,978 | 64.4 K to 63 K (-2.14 %) |
| Mar 11 2011 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Option Exercise | M | 36.80 | 20,000 | 736,000 | 10,000 | |
| Mar 11 2011 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Sell | S | 56.42 | 5,000 | 282,100 | 10,000 | 15 K to 10 K (-33.33 %) |
| Mar 11 2011 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Sell | S | 56.42 | 20,000 | 1,128,400 | 15,000 | 35 K to 15 K (-57.14 %) |
| Mar 11 2011 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Buy | M | 36.80 | 20,000 | 736,000 | 35,000 | 15 K to 35 K (+133.33 %) |
| Mar 08 2011 | ACT | Actavis, Inc. | PAONESSA ALBERT III | EVP & COO of Anda, ... | Payment of Exercise | F | 56.79 | 1,511 | 85,810 | 45,430 | 46.9 K to 45.4 K (-3.22 %) |
| Mar 08 2011 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Payment of Exercise | F | 56.79 | 1,722 | 97,792 | 39,860 | 41.6 K to 39.9 K (-4.14 %) |
| Mar 08 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Payment of Exercise | F | 56.79 | 1,374 | 78,029 | 47,081 | 48.5 K to 47.1 K (-2.84 %) |
| Mar 08 2011 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Payment of Exercise | F | 56.79 | 1,295 | 73,543 | 30,973 | 32.3 K to 31 K (-4.01 %) |
| Mar 08 2011 | ACT | Actavis, Inc. | Carmichael Clare | SR VP, Human Resour ... | Payment of Exercise | F | 56.79 | 1,036 | 58,834 | 16,447 | 17.5 K to 16.4 K (-5.93 %) |
| Mar 08 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Payment of Exercise | F | 56.79 | 2,747 | 156,002 | 64,353 | 67.1 K to 64.4 K (-4.09 %) |
| Mar 08 2011 | ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Payment of Exercise | F | 56.79 | 11,933 | 677,675 | 277,072 | 289 K to 277.1 K (-4.13 %) |
| Mar 07 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Option Exercise | M | 48.90 | 6,500 | 317,850 | 0 | |
| Mar 07 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Option Exercise | M | 27.88 | 7,497 | 209,016 | 7,500 | |
| Mar 07 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Sell | S | 57.09 | 10,978 | 626,734 | 48,455 | 59.4 K to 48.5 K (-18.47 %) |
| Mar 07 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Buy | M | 48.90 | 6,500 | 317,850 | 59,433 | 52.9 K to 59.4 K (+12.28 %) |
| Mar 07 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Buy | M | 27.88 | 7,497 | 209,016 | 52,933 | 45.4 K to 52.9 K (+16.50 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | Wilkinson George Fred | Exec.VP-Global Bran ... | Grant | A | 0.00 | 18,040 | 0 | 44,608 | 26.6 K to 44.6 K (+67.90 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | Stewart Robert A | Exec VP,Global Oper ... | Grant | A | 0.00 | 14,365 | 0 | 46,365 | 32 K to 46.4 K (+44.89 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | PAONESSA ALBERT III | EVP & COO of Anda, ... | Grant | A | 0.00 | 10,230 | 0 | 46,941 | 36.7 K to 46.9 K (+27.87 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | Olafsson Sigurdur O | EXEC VP, GLOBAL GEN ... | Grant | A | 0.00 | 10,851 | 0 | 35,851 | 25 K to 35.9 K (+43.40 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Grant | A | 0.00 | 9,794 | 0 | 41,582 | 31.8 K to 41.6 K (+30.81 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | Mayr Charles M | Sr VP,Corporate Aff ... | Grant | A | 0.00 | 5,852 | 0 | 12,425 | 6.6 K to 12.4 K (+89.03 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Grant | A | 0.00 | 12,269 | 0 | 45,436 | 33.2 K to 45.4 K (+36.99 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 48.85 | 7,500 | 366,375 | 0 | |
| Mar 04 2011 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 56.36 | 7,500 | 422,700 | 32,268 | 39.8 K to 32.3 K (-18.86 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 48.85 | 7,500 | 366,375 | 39,768 | 32.3 K to 39.8 K (+23.24 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Grant | A | 0.00 | 7,119 | 0 | 32,268 | 25.1 K to 32.3 K (+28.31 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Option Exercise | M | 48.90 | 5,000 | 244,500 | 0 | |
| Mar 04 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Sell | S | 57.11 | 5,000 | 285,550 | 67,100 | 72.1 K to 67.1 K (-6.93 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Buy | M | 48.90 | 5,000 | 244,500 | 72,100 | 67.1 K to 72.1 K (+7.45 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Grant | A | 0.00 | 15,034 | 0 | 67,100 | 52.1 K to 67.1 K (+28.87 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Grant | A | 0.00 | 67,710 | 0 | 289,005 | 221.3 K to 289 K (+30.60 %) |
| Feb 23 2011 | ACT | Actavis, Inc. | FELDMAN MICHEL J | Director | Option Exercise | M | 48.48 | 30,000 | 1,454,400 | 0 | |
| Feb 23 2011 | ACT | Actavis, Inc. | FELDMAN MICHEL J | Director | Sell | S | 54.98 | 30,000 | 1,649,400 | 10,000 | 40 K to 10 K (-75.00 %) |
| Feb 23 2011 | ACT | Actavis, Inc. | FELDMAN MICHEL J | Director | Buy | M | 48.48 | 30,000 | 1,454,400 | 40,000 | 10 K to 40 K (+300.00 %) |
| Jan 04 2011 | ACT | Actavis, Inc. | Russillo Thomas R | EVP, Global Generic ... | Payment of Exercise | F | 51.65 | 5,502 | 284,178 | 57,868 | 63.4 K to 57.9 K (-8.68 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | Russillo Thomas R | EVP, Global Generic ... | Option Exercise | M | 25.86 | 48,402 | 1,251,676 | 0 | |
| Dec 17 2010 | ACT | Actavis, Inc. | Russillo Thomas R | EVP, Global Generic ... | Option Exercise | M | 25.86 | 11,598 | 299,924 | 0 | |
| Dec 17 2010 | ACT | Actavis, Inc. | Russillo Thomas R | EVP, Global Generic ... | Sell | S | 50.00 | 60,000 | 3,000,000 | 63,370 | 123.4 K to 63.4 K (-48.63 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | Russillo Thomas R | EVP, Global Generic ... | Buy | M | 25.86 | 48,402 | 1,251,676 | 123,370 | 75 K to 123.4 K (+64.56 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | Russillo Thomas R | EVP, Global Generic ... | Buy | M | 25.86 | 11,598 | 299,924 | 74,968 | 63.4 K to 75 K (+18.30 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Option Exercise | M | 48.48 | 30,000 | 1,454,400 | 0 | |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Sell | S | 51.00 | 8,952 | 456,552 | 19,334 | 28.3 K to 19.3 K (-31.65 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Sell | S | 51.01 | 9,010 | 459,600 | 28,286 | 37.3 K to 28.3 K (-24.16 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Sell | S | 51.02 | 4,210 | 214,794 | 37,296 | 41.5 K to 37.3 K (-10.14 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Sell | S | 51.03 | 200 | 10,205 | 41,506 | 41.7 K to 41.5 K (-0.48 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Sell | S | 51.03 | 3,210 | 163,806 | 41,706 | 44.9 K to 41.7 K (-7.15 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Sell | S | 51.04 | 3,507 | 178,997 | 44,916 | 48.4 K to 44.9 K (-7.24 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Sell | S | 51.05 | 200 | 10,209 | 48,423 | 48.6 K to 48.4 K (-0.41 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Sell | S | 51.05 | 711 | 36,297 | 48,623 | 49.3 K to 48.6 K (-1.44 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Buy | M | 48.48 | 30,000 | 1,454,400 | 49,334 | 19.3 K to 49.3 K (+155.17 %) |
| Dec 14 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Option Exercise | M | 45.88 | 1,133 | 51,976 | 0 | |
| Dec 14 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Option Exercise | M | 45.88 | 1,367 | 62,711 | 0 | |
| Dec 14 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Sell | S | 49.00 | 1,708 | 83,692 | 33,167 | 34.9 K to 33.2 K (-4.90 %) |
| Dec 14 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Sell | S | 49.01 | 792 | 38,816 | 34,875 | 35.7 K to 34.9 K (-2.22 %) |
| Dec 14 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Buy | M | 45.88 | 1,133 | 51,976 | 35,667 | 34.5 K to 35.7 K (+3.28 %) |
| Dec 14 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Buy | M | 45.88 | 1,367 | 62,711 | 34,534 | 33.2 K to 34.5 K (+4.12 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Option Exercise | M | 26.60 | 10,000 | 266,000 | 20,000 | |
| Dec 17 2010 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Buy | M | 26.60 | 10,000 | 266,000 | 26,441 | 16.4 K to 26.4 K (+60.82 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Sell | S | 51.08 | 384 | 19,615 | 16,441 | 16.8 K to 16.4 K (-2.28 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Sell | S | 51.07 | 100 | 5,107 | 16,825 | 16.9 K to 16.8 K (-0.59 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Sell | S | 51.07 | 2,700 | 137,892 | 16,925 | 19.6 K to 16.9 K (-13.76 %) |
| Dec 17 2010 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Sell | S | 51.07 | 2,043 | 104,340 | 19,625 | 21.7 K to 19.6 K (-9.43 %) |
| Dec 15 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Option Exercise | M | 46.31 | 1,285 | 59,508 | 0 | |
| Dec 15 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Option Exercise | M | 46.31 | 8,715 | 403,592 | 0 | |
| Dec 15 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Sell | S | 49.50 | 1,285 | 63,608 | 33,167 | 34.5 K to 33.2 K (-3.73 %) |
| Dec 15 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Sell | S | 49.50 | 3,715 | 183,893 | 34,452 | 38.2 K to 34.5 K (-9.73 %) |
| Dec 15 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Sell | S | 49.70 | 5,000 | 248,500 | 38,167 | 43.2 K to 38.2 K (-11.58 %) |
| Dec 15 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Buy | M | 46.31 | 1,285 | 59,508 | 43,167 | 41.9 K to 43.2 K (+3.07 %) |
| Dec 15 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Buy | M | 46.31 | 8,715 | 403,592 | 41,882 | 33.2 K to 41.9 K (+26.28 %) |
| Nov 29 2010 | ACT | Actavis, Inc. | PAONESSA ALBERT III | EVP & COO of Anda, ... | Sell | S | 48.44 | 4,000 | 193,760 | 36,711 | 40.7 K to 36.7 K (-9.83 %) |
| Dec 07 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 51.00 | 3,639 | 185,589 | 25,149 | 28.8 K to 25.1 K (-12.64 %) |
| Sep 02 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Payment of Exercise | F | 44.15 | 244 | 10,773 | 33,167 | 33.4 K to 33.2 K (-0.73 %) |
| Sep 02 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Payment of Exercise | F | 44.15 | 216 | 9,536 | 28,788 | 29 K to 28.8 K (-0.74 %) |
| Sep 02 2010 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Payment of Exercise | F | 44.15 | 305 | 13,466 | 52,066 | 52.4 K to 52.1 K (-0.58 %) |
| Sep 02 2010 | ACT | Actavis, Inc. | Olafsson Sigurdur O | EXEC VP, GLOBAL GEN ... | Grant | A | 0.00 | 20,000 | 0 | 25,000 | 5 K to 25 K (+400.00 %) |
| Sep 02 2010 | ACT | Actavis, Inc. | Olafsson Sigurdur O | EXEC VP, GLOBAL GEN ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Aug 25 2010 | ACT | Actavis, Inc. | HUMMEL ALBERT F | Director | Sell | S | 42.07 | 20,000 | 841,420 | 149,514 | 169.5 K to 149.5 K (-11.80 %) |
| Aug 24 2010 | ACT | Actavis, Inc. | FELDMAN MICHEL J | Director | Sell | S | 42.48 | 8,334 | 354,012 | 10,000 | 18.3 K to 10 K (-45.46 %) |
| Aug 17 2010 | ACT | Actavis, Inc. | Carmichael Clare | SR VP, Human Resour ... | Sell | S | 42.32 | 1,118 | 47,315 | 17,483 | 18.6 K to 17.5 K (-6.01 %) |
| Aug 17 2010 | ACT | Actavis, Inc. | Carmichael Clare | SR VP, Human Resour ... | Sell | S | 42.32 | 200 | 8,464 | 18,601 | 18.8 K to 18.6 K (-1.06 %) |
| Aug 16 2010 | ACT | Actavis, Inc. | Carmichael Clare | SR VP, Human Resour ... | Payment of Exercise | F | 41.53 | 632 | 26,247 | 18,801 | 19.4 K to 18.8 K (-3.25 %) |
| Jun 14 2010 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 42.58 | 5,000 | 212,900 | 5,000 | 10 K to 5 K (-50.00 %) |
| Jun 09 2010 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Option Exercise | M | 29.03 | 5,000 | 145,150 | 0 | |
| Jun 09 2010 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Option Exercise | M | 27.84 | 12,000 | 334,080 | 0 | |
| Jun 09 2010 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Sell | S | 42.27 | 100 | 4,227 | 15,000 | 15.1 K to 15 K (-0.66 %) |
| Jun 09 2010 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Sell | S | 42.26 | 4,901 | 207,116 | 15,100 | 20 K to 15.1 K (-24.50 %) |
| Jun 09 2010 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Sell | S | 42.13 | 400 | 16,852 | 20,001 | 20.4 K to 20 K (-1.96 %) |
| Jun 09 2010 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Sell | S | 42.16 | 16,600 | 699,856 | 20,401 | 37 K to 20.4 K (-44.86 %) |
| Jun 09 2010 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Buy | M | 29.03 | 5,000 | 145,150 | 37,001 | 32 K to 37 K (+15.62 %) |
| Jun 09 2010 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Buy | M | 27.84 | 12,000 | 334,080 | 32,001 | 20 K to 32 K (+60.00 %) |
| May 11 2010 | ACT | Actavis, Inc. | WEISS FRED G | Director | Grant | A | 0.00 | 5,000 | 0 | 19,334 | 14.3 K to 19.3 K (+34.88 %) |
| May 11 2010 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| May 11 2010 | ACT | Actavis, Inc. | TAYLOR RONALD R | Director | Grant | A | 0.00 | 5,000 | 0 | 20,001 | 15 K to 20 K (+33.33 %) |
| May 11 2010 | ACT | Actavis, Inc. | KLEMA CATHY | Director | Grant | A | 0.00 | 5,000 | 0 | 21,668 | 16.7 K to 21.7 K (+30.00 %) |
| May 11 2010 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Grant | A | 0.00 | 5,000 | 0 | 20,001 | 15 K to 20 K (+33.33 %) |
| May 11 2010 | ACT | Actavis, Inc. | HUMMEL ALBERT F | Director | Grant | A | 0.00 | 5,000 | 0 | 169,514 | 164.5 K to 169.5 K (+3.04 %) |
| May 11 2010 | ACT | Actavis, Inc. | FELDMAN MICHEL J | Director | Grant | A | 0.00 | 5,000 | 0 | 18,334 | 13.3 K to 18.3 K (+37.50 %) |